Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    J Affect Disord. 2011 May;130(3):470-7. doi: 10.1016/j.jad.2010.10.043. Epub 2010 Nov 24.

    Depression and eating disorders: treatment and course.

    Source

    Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA. dmischoulon@partners.org

    Abstract

    BACKGROUND:

    We examined the course of major depressive disorder (MDD) and predictors of MDD recovery and relapse in a longitudinal sample of women with eating disorders (ED).

    METHODS:

    246 Boston-area women with DSM-IV anorexia nervosa-restricting (ANR; n=51), AN-binge/purge (ANBP; n=85), and bulimia nervosa (BN; n=110) were recruited between 1987 and 1991 and interviewed using the Eating Disorders Longitudinal Interval Follow-up Evaluation (LIFE-EAT-II) every 6-12 months for up to 12 years. 100 participants had MDD at study intake and 45 developed MDD during the study. Psychological functioning and treatment were assessed.

    RESULTS:

    Times to MDD onset (1 week-4.3 years), recovery (8 weeks-8.7 years), and relapse (1 week-5.2 years) varied. 70% recovered from MDD, but 65% subsequently relapsed. ANR patients were significantly less likely to recover from MDD than ANBP patients (p=0.029). Better psychological functioning and history of MDD were associated with higher chance of MDD recovery. Higher baseline depressive severity and full recovery from ED were associated with greater likelihood of MDD relapse; increased weight loss was somewhat protective. Adequate antidepressant treatment was given to 72% of patients with MDD and generally continued after MDD recovery. Time on antidepressants did not predict MDD recovery (p=0.27) or relapse (p=0.26).

    LIMITATIONS:

    Small ED diagnostic subgroups; lack of non-ED control group.

    CONCLUSIONS:

    The course of MDD in EDs is protracted; MDD recovery may depend on ED type. Antidepressants did not impact likelihood of MDD recovery, nor protect against relapse, which may impact on treatment strategies for comorbid MDD and EDs.

    Copyright © 2010 Elsevier B.V. All rights reserved.

    PMID:
    21109307
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3085695
    Free PMC Article

    Images from this publication.See all images (2)Free text

    Figure 2
    Figure 1

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk